drugset / Trial / NCT04055194

Antenatal Tranexamic Acid in Women With Symptomatic Placenta Previa

NCT04055194

Phase 2/3 Unknown 200 enrolled Ain Shams University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

200 pregnant women with symptomatic placenta previa with previous bleeding attacks attending Ain Shams University maternity hospital will be recruited and randomized to receive either tranexamic acid tablets (500mg four times daily) or placebo. Amount of bleeding during antepartum bleeding attacks will be estimated (by hemoglobin change from baseline at admission till delivery).

Timeline

Start
2019-08-01
Primary completion
2020-07-01
Completion
2020-08-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tranexamic Acid Small molecule 500 mg Oral

Indications